AR019664A1 - COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES - Google Patents

COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES

Info

Publication number
AR019664A1
AR019664A1 ARP990102842A AR019664A1 AR 019664 A1 AR019664 A1 AR 019664A1 AR P990102842 A ARP990102842 A AR P990102842A AR 019664 A1 AR019664 A1 AR 019664A1
Authority
AR
Argentina
Prior art keywords
treatment
cartilago
diseases
composition
optionally substituted
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AR019664A1 publication Critical patent/AR019664A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Abstract

Una composicion farmacéutica para la prevencion y/o tratamiento de una enfermedad del cartílago, que comprende un compuesto (I) de formula(1) en donde elanillo A es un anillo bencénico opcionalmente sustituido; R es un átomo de hidrogeno o un grupo hidrocarbonado opcionalmente sustituido; B es un grupocarboxilo opcionalmente esterificado o convertido en amida; X es -CH(OH)- o -CO-; k es 0 o 1; y k es 0, 1 o 2, o su sal y método para su uso.A pharmaceutical composition for the prevention and / or treatment of a cartilage disease, comprising a compound (I) of formula (1) in which Elanillo A is an optionally substituted benzene ring; R is a hydrogen atom or an optionally substituted hydrocarbon group; B is an optionally esterified or converted to amidecarboxyl group; X is -CH (OH) - or -CO-; k is 0 or 1; and k is 0, 1 or 2, or its salt and method of use.

ARP990102842 1998-06-15 1999-06-15 COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES AR019664A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16750798 1998-06-15

Publications (1)

Publication Number Publication Date
AR019664A1 true AR019664A1 (en) 2002-03-13

Family

ID=15850970

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990102842 AR019664A1 (en) 1998-06-15 1999-06-15 COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES

Country Status (5)

Country Link
EP (1) EP1087774A2 (en)
AR (1) AR019664A1 (en)
AU (1) AU4165699A (en)
CA (1) CA2334815A1 (en)
WO (1) WO1999065474A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5194999A (en) 1998-08-07 2000-02-28 Takeda Chemical Industries Ltd. Benzothiepin derivatives, process for the preparation of the same and uses thereof
US20030187054A1 (en) * 2000-03-10 2003-10-02 Shunsuke Nagao Preparations for chondrogenesis
WO2001089521A1 (en) * 2000-05-23 2001-11-29 Takeda Chemical Industries, Ltd. Medicinal compositions containing thiophene derivatives
FI129515B (en) 2020-11-06 2022-03-31 Salarusta Oy Hica for use in prophylaxis and/or treatment of a disease or condition involving degradation of cartilage and/or disruption of cartilage homeostasis and/or integrity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK656789A (en) * 1988-12-28 1990-06-29 Takeda Chemical Industries Ltd BENZOHETEROCYCLIC COMPOUNDS
ATE203020T1 (en) * 1990-05-30 2001-07-15 Takeda Chemical Industries Ltd SULFUR CONTAINING HETEROCYCLIC COMPOUNDS
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
CA2221784A1 (en) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Osteogenetic promoting pharmaceutical composition
EP0949927B1 (en) * 1996-08-26 2002-10-16 Takeda Chemical Industries, Ltd. Pharmaceutical composition containing osteogenesis-promoting substance and a polyethylene glycol

Also Published As

Publication number Publication date
WO1999065474A3 (en) 2000-04-06
AU4165699A (en) 2000-01-05
WO1999065474A2 (en) 1999-12-23
EP1087774A2 (en) 2001-04-04
CA2334815A1 (en) 1999-12-23

Similar Documents

Publication Publication Date Title
ES2193142T3 (en) USE OF BENZOTIOPHENES FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA.
BR9611015A (en) Compound, pharmaceutical composition and process for the treatment of an inflammatory disease susceptible to treatment with a non-toxic non-steroidal anti-inflammatory agent, pharmaceutically acceptable salt, use of a compound
ES2124612T3 (en) DIHYDRODIBENZE (B, F) AZEPINS, SUBSTITUTED, METHOD FOR THE PREPARATION, THEIR USE IN THE TREATMENT OF VARIOUS CENTRAL NERVOUS SYSTEM DISORDERS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
BR0108600A (en) Compound, process for preparing it, pharmaceutical composition, process for preparing it, use of a compound, and methods for treating a chemokine-mediated disease and for treating an inflammatory disease
BR0010555A (en) Neuraminidase Inhibitors
UY26199A1 (en) NEW BENZENE DERIVATIVES, A PROCEDURE FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
BR9406979A (en) Compound, pharmaceutical composition for treating an inflammatory disease susceptible to treatment with a non-steroidal anti-inflammatory agent processes for treating an inflammatory disease and for preparing a pharmaceutically acceptable salt compound use of a non-steroidal anti-inflammatory pharmaceutical composition compound
BR0113776A (en) Composition of selected fused pyrrolocarbazoles and method for treating and preventing various diseases using said composition
BRPI0111116B8 (en) thrombopoietin mimics
YU56995A (en) ONLY DERIVED INDOLA
BR0010119A (en) Composition to prevent or treat dementia containing a hydroxycinnamic acid derivative or an extract from a genus angelicae plant containing the same
RU93005334A (en) DERIVATIVES OF STEROIDS FOR THE TREATMENT OF HYPERTROPHY OF THE PROSTATE GLAND, METHOD FOR PRODUCING THEM, USE, PHARMACEUTICAL COMPOSITION
ES2155566T3 (en) USE OF RIFAMYCIN DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES BY CLAMIDIA.
AR019496A1 (en) AZALIDAS OF 13 MEMBERS, PHARMACEUTICAL COMPOSITIONS, USE IN THE PREPARATION OF MEDICINES AND PREPARATION OF THE SAME
ES2055035T3 (en) A PROCESS FOR THE PREPARATION OF AN ANTHRACICLINE GLYCOSIDE.
CO4820432A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF RHINITIS INCLUDING ACID 2- (4- (DIFENILMETIL) -1-PIPERACINIL) -ACE- TICO OR DERIVED AMIDE AND A SELECTED COMPOUND OF PSEUDOE FEDRINE, PHENYLPROPANOLAMINE AND PHENYLEPHRINE
ES2156120T3 (en) ARILAMIDIC DERIVATIVES.
BR9507231A (en) Use of carboxylic acid derivatives for drug production
KR970074763A (en) Fluorinated Vitamin D₃ Analogs
IS1664B (en) New method of producing substituted 4-phenyl-4-piperidinecarboxamide which has both local anesthetic and analgesic effect
AR003137A1 (en) A PHARMACEUTICAL COMPOSITION TO TREAT LEUKEMIA
ES2181927T3 (en) DERIVATIVES OF 1-METILCARBAPENEM.
ATE181333T1 (en) AZIRDINE DERIVATIVES, THEIR PREPARATION AND USE
AR012124A1 (en) A PROCEDURE FOR THE PREPARATION OF TIAZOLIDINADIONA DERIVATIVES, TIAZOLIDINADIONA DERIVATIVES, THEIR USE AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH DERIVATIVES.
AR019664A1 (en) COMPOSITION FOR THE TREATMENT OF CARTILAGO DISEASES